Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Is Hemoglobin A1c (HbA1C) Level an Independent Predictor of Adverse Outcomes in Patients with Acute Ischemic Stroke undergoing Endovascular Treatment?
Cerebrovascular Disease and Interventional Neurology
(-)
239
Authors/Disclosures
Abeer Alsalamah (Prince Sultan Military Medical City)
PRESENTER 		No disclosure on file
No disclosure on file
Taqi T. Zafar, MD (SUNY Health Science Center, Upstate) No disclosure on file
No disclosure on file
Ali Saeed, MD No disclosure on file
Mohammad Owais, MD (Baptist Health) No disclosure on file
No disclosure on file
Vikram Jadhav, MD (Minnesota Stroke Network) No disclosure on file
No disclosure on file
Syed I. Hussain, MD (Cleveland Clinic Abu Dhabi) Dr. Hussain has nothing to disclose.
Hamza I. Maqsood, MD (Dept of Neurology) Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.